Biocryst Pharmaceuticals (BCRX) Property, Plant & Equipment (Net) Growth (1y) (2011 - 2026)
Biocryst Pharmaceuticals (BCRX) Property, Plant & Equipment (Net) Growth (1y) (2011 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PP&E (Net) Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.92 Bn | 42.96 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.19 Bn | 39.53 Bn | 2.15 Bn | -18.34% |
| 3 | Zoetis | 31.74 Bn | 30.06 Bn | 1.05 Bn | 6.19% |
| 4 | Takeda Pharmaceutical | 28.67 Bn | 22.87 Bn | 5.10 Bn | -0.59% |
| 5 | United Therapeutics | 22.22 Bn | 19.56 Bn | 683.80 Mn | 41.67% |
| 6 | Viatris | 18.71 Bn | 17.83 Bn | 1.46 Bn | -7.68% |
| 7 | Neurocrine Biosciences | 15.55 Bn | 15.16 Bn | 935.80 Mn | -1.31% |
| 8 | Elanco Animal Health | 11.80 Bn | 11.27 Bn | 798.00 Mn | 3.98% |
| 9 | Dr Reddys Laboratories | 10.13 Bn | 9.97 Bn | - | 3.94% |
| 10 | Biocryst Pharmaceuticals | 2.46 Bn | 2.11 Bn | 214.41 Mn | 7.11% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 7.11% |
| Mar 31, 2026 | 23.38% |
| Dec 31, 2025 | 12.94% |
| Sep 30, 2025 | 13.14% |
| Jun 30, 2025 | 10.36% |
| Mar 31, 2025 | -3.04% |
| Dec 31, 2024 | -1.68% |
| Sep 30, 2024 | -17.54% |
| Jun 30, 2024 | -9.18% |
| Mar 31, 2024 | -6.51% |
| Dec 31, 2023 | -8.20% |
| Sep 30, 2023 | 6.32% |
| Jun 30, 2023 | -3.03% |
| Mar 31, 2023 | -4.81% |
| Dec 31, 2022 | -1.11% |
| Sep 30, 2022 | 8.11% |
| Jun 30, 2022 | 13.47% |
| Mar 31, 2022 | 25.07% |
| Dec 31, 2021 | 22.51% |
| Sep 30, 2021 | 9.62% |